ABOUT US.

Based in Fremont, California, Silver Bullet Therapeutics is advancing implant technology through the development of innovative antimicrobial solutions.

Backed by over fifteen years of research, testing, and preclinical development, the company is focused on addressing the critical need to reduce contamination associated with medical device implants while bringing transformative technology to the orthopedic market.

FOUNDERS

  • Paul Chirico

    PRESIDENT & CEO

    Paul Chirico brings nearly 50 years of medical technology experience, including over 20 years in orthopedics and spine. As Founder and CEO of SpineAlign Medical and a former executive at Micrus Endovascular, Incyte Genomics, and Avocet Medical, Paul has led the development of innovative healthcare technologies and now guides the advancement of OrthoFuzIon™ at Silver Bullet Therapeutics.

  • Bohdan Chopko, MD, PHD

    CO-FOUNDER

    Dr. Bohdan Chopko is a Professor of Neurosurgery and Complex Spine at Stanford University with extensive experience in spinal surgery, research, and medical innovation. As Co-Founder of Silver Bullet Therapeutics, he provides clinical expertise and insight to support the development of OrthoFuzIon™ and advanced antimicrobial implant technologies.

  • Houdin Dehnad, PhD

    CO-FOUNDER & VP of R&D

    Houdin Dehnad, PhD, brings over 30 years of medical technology experience focused on biomaterials, implant materials, and medical device innovation. With previous experience at Alza, Micrus, and Guidant, Dr. Dehnad leads the research and technical efforts behind OrthoFuzIon™, leveraging his expertise in materials science and engineering to support Silver Bullet Therapeutics’ antimicrobial implant solutions.

BOARD OF DIRECTORS

  • John Barr, MD

    BOARD DIRECTOR

    Dr. John Barr is a Professor of Radiology and Neurosurgery at UT Southwestern Medical Center with extensive experience in spinal care, medical device innovation, and healthcare entrepreneurship. As an accomplished physician, entrepreneur, and investor, Dr. Barr provides clinical expertise and strategic guidance to Silver Bullet Therapeutics.

  • Roger Guidi

    BOARD DIRECTOR

    Roger Guidi brings over 45 years of medical technology experience spanning startups, Fortune 50 companies, and healthcare innovation. With leadership experience at Johnson & Johnson, VISX, and Hourglass Technologies, as well as nine years with JJDC, Roger provides operational expertise to Silver Bullet Therapeutics.

  • Robert McCormick

    BOARD DIRECTOR

    Robert McCormick brings over 50 years of medical technology experience spanning executive leadership, healthcare innovation, and corporate strategy. As the former CEO of Laserscope and a member of numerous corporate and philanthropic boards, Robert serves as a strategic advisor, drawing on decades of executive leadership in medical technology.